Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Critical and subcritical ischaemia

J H Wolfe1, M G Wyatt

  • 1Regional Vascular Unit, St Mary's Hospital, London, U.K.

European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mifepristone-inducible transgene expression in neural progenitor cells in vitro and in vivo.

Gene therapy·2016
Same author

PATTERN CLUSTERING BY MULTIVARIATE MIXTURE ANALYSIS.

Multivariate behavioral research·2016
Same author

Comparative Cluster Analysis Of Patterns Of Vocational Interest.

Multivariate behavioral research·2016
Same author

Predicted shortage of vascular surgeons in the United Kingdom: A matter for debate?

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·2015
Same author

Comment on "Atlantic and Pacific multidecadal oscillations and Northern Hemisphere temperatures".

Science (New York, N.Y.)·2015
Same author

The vascular surgery workforce: a survey of consultant vascular surgeons in the UK, 2014.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2014

This study stratifies leg ischemia patients into low-risk (subcritical) and high-risk (critical) groups. High-risk patients benefit significantly from arterial reconstruction, improving limb salvage rates compared to conservative treatment.

Area of Science:

  • Vascular Surgery
  • Clinical Outcomes Research
  • Peripheral Artery Disease

Background:

  • Critical leg ischemia poses a significant risk of major amputation and mortality.
  • Accurate risk stratification is essential for guiding treatment decisions and improving patient outcomes.
  • Current classifications may not adequately differentiate between risk levels, impacting study interpretations.

Purpose of the Study:

  • To stratify patients with leg ischemia into distinct high-risk and low-risk groups.
  • To analyze the outcomes (limb salvage and mortality) for each risk group.
  • To provide a more realistic perspective on the effectiveness of reconstructive surgery.

Main Methods:

  • Systematic evaluation of 20 publications encompassing 6118 patients with critical leg ischemia.

Related Experiment Videos

  • Identification of low-risk (subcritical) and high-risk (critical) groups based on defined clinical and hemodynamic criteria (ankle pressure > 40 mmHg vs. < 40 mmHg, presence of tissue loss).
  • Analysis of patient and limb outcomes, including major amputation and mortality rates, with and without surgical intervention.

    • Main Results:

    • Two distinct groups were identified: subcritical (n=4089) and critical (n=2029).
    • Overall 1, 3, and 5-year mortality rates were 26%, 44%, and 56%, respectively.
    • For high-risk patients, conservative treatment led to 95% amputation, while arterial reconstruction reduced this to 25%; limb salvage was 93% with reconstruction.
    • Low-risk patients had a 27% chance of limb salvage with conservative treatment.

    Conclusions:

    • Reconstructive surgery outcomes should be interpreted within the context of patient risk stratification.
    • For high-risk critical ischemia, 100% arterial patency correlates with 93% limb salvage at one year.
    • Future research must differentiate between subcritical and critical ischemia groups to accurately assess treatment efficacy and guide pharmacotherapy trials.